{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:20:24Z","timestamp":1794561624021,"version":"4.9.1"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1038\/s41582-023-00846-7","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T16:02:03Z","timestamp":1691683323000},"page":"525-541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases"],"prefix":"10.1038","volume":"19","author":[{"given":"Sukriti","family":"Nag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-1752","authenticated-orcid":false,"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"846_CR1","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1128\/jvi.69.6.3584-3596.1995","volume":"69","author":"SH Ou","year":"1995","unstructured":"Ou, S. H., Wu, F., Harrich, D., Garcia-Martinez, L. F. & Gaynor, R. B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 3584\u20133596 (1995).","journal-title":"J. Virol."},{"key":"846_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602\u2013611 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"846_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"846_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","volume":"120","author":"O Yokota","year":"2010","unstructured":"Yokota, O. et al. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol. 120, 55\u201366 (2010).","journal-title":"Acta Neuropathol."},{"key":"846_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-131880","volume":"39","author":"WD Brenowitz","year":"2014","unstructured":"Brenowitz, W. D., Monsell, S. E., Schmitt, F. A., Kukull, W. A. & Nelson, P. T. Hippocampal sclerosis of aging is a key Alzheimer\u2019s disease mimic: clinical-pathologic correlations and comparisons with both Alzheimer\u2019s disease and non-tauopathic frontotemporal lobar degeneration. J. Alzheimers Dis. 39, 691\u2013702 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"846_CR6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"846_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz224","volume":"142","author":"KA Josephs","year":"2019","unstructured":"Josephs, K. A. et al. LATE to the PART-y. Brain 142, e47 (2019).","journal-title":"Brain"},{"key":"846_CR8","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.2019.12232","volume":"322","author":"J Abbasi","year":"2019","unstructured":"Abbasi, J. Debate sparks over LATE, a recently recognized dementia. J. Am. Med. Assoc. 322, 914\u2013916 (2019).","journal-title":"J. Am. Med. Assoc."},{"key":"846_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz226","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Reply: LATE to the PART-y. Brain 142, e48 (2019).","journal-title":"Brain"},{"key":"846_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine, T. J. et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 123, 1\u201311 (2012).","journal-title":"Acta Neuropathol."},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/NEN.0b013e3181ee7d85","volume":"69","author":"AC McKee","year":"2010","unstructured":"McKee, A. C. et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 69, 918\u2013929 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab, C., Arai, T., Hasegawa, M., Yu, S. & McGeer, P. L. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J. Neuropathol. Exp. Neurol. 67, 1159\u20131165 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR13","doi-asserted-by":"publisher","first-page":"6826","DOI":"10.1074\/jbc.M109.061846","volume":"285","author":"CF Sephton","year":"2010","unstructured":"Sephton, C. F. et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 285, 6826\u20136834 (2010).","journal-title":"J. Biol. Chem."},{"key":"846_CR14","doi-asserted-by":"publisher","first-page":"36337","DOI":"10.1074\/jbc.M104236200","volume":"276","author":"E Buratti","year":"2001","unstructured":"Buratti, E. & Baralle, F. E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276, 36337\u201336343 (2001).","journal-title":"J. Biol. Chem."},{"key":"846_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1083\/jcb.201302044","volume":"201","author":"YR Li","year":"2013","unstructured":"Li, Y. R., King, O. D., Shorter, J. & Gitler, A. D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361\u2013372 (2013).","journal-title":"J. Cell Biol."},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/febs.13651","volume":"283","author":"M Mompean","year":"2016","unstructured":"Mompean, M. et al. The TDP-43 N-terminal domain structure at high resolution. FEBS J. 283, 1242\u20131260 (2016).","journal-title":"FEBS J."},{"key":"846_CR17","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1042\/BCJ20160499","volume":"474","author":"AF Harrison","year":"2017","unstructured":"Harrison, A. F. & Shorter, J. RNA-binding proteins with prion-like domains in health and disease. Biochem. J. 474, 1417\u20131438 (2017).","journal-title":"Biochem. J."},{"key":"846_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ de Boer","year":"2020","unstructured":"de Boer, E. M. J. et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 92, 86\u201395 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"846_CR19","doi-asserted-by":"publisher","first-page":"a024554","DOI":"10.1101\/cshperspect.a024554","volume":"7","author":"L Guo","year":"2017","unstructured":"Guo, L. & Shorter, J. Biology and pathobiology of TDP-43 and emergent therapeutic strategies. Cold Spring Harb. Perspect. Med. 7, a024554 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"846_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14327","author":"J Gao","year":"2018","unstructured":"Gao, J., Wang, L., Huntley, M. L., Perry, G. & Wang, X. Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem. https:\/\/doi.org\/10.1111\/jnc.14327 (2018).","journal-title":"J. Neurochem."},{"key":"846_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A. & Patel, B. K. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 12, 25 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"846_CR22","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1074\/jbc.M110.166587","volume":"286","author":"AS Lalmansingh","year":"2011","unstructured":"Lalmansingh, A. S., Urekar, C. J. & Reddi, P. P. TDP-43 is a transcriptional repressor: the testis-specific mouse acrv1 gene is a TDP-43 target in vivo. J. Biol. Chem. 286, 10970\u201310982 (2011).","journal-title":"J. Biol. Chem."},{"key":"846_CR23","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1021\/pr901076y","volume":"9","author":"BD Freibaum","year":"2010","unstructured":"Freibaum, B. D., Chitta, R. K., High, A. A. & Taylor, J. P. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res. 9, 1104\u20131120 (2010).","journal-title":"J. Proteome Res."},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.aab0983","volume":"349","author":"JP Ling","year":"2015","unstructured":"Ling, J. P., Pletnikova, O., Troncoso, J. C. & Wong, P. C. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349, 650\u2013655 (2015).","journal-title":"Science"},{"key":"846_CR25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling, S. C., Polymenidou, M. & Cleveland, D. W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416\u2013438 (2013).","journal-title":"Neuron"},{"key":"846_CR26","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1523\/JNEUROSCI.2350-13.2014","volume":"34","author":"L Liu-Yesucevitz","year":"2014","unstructured":"Liu-Yesucevitz, L. et al. ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J. Neurosci. 34, 4167\u20134174 (2014).","journal-title":"J. Neurosci."},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"37572","DOI":"10.1074\/jbc.M505557200","volume":"280","author":"E Buratti","year":"2005","unstructured":"Buratti, E. et al. TDP-43 binds heterogeneous nuclear ribonucleoprotein A\/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280, 37572\u201337584 (2005).","journal-title":"J. Biol. Chem."},{"key":"846_CR28","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1073\/pnas.1112427109","volume":"109","author":"Y Kawahara","year":"2012","unstructured":"Kawahara, Y. & Mieda-Sato, A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl Acad. Sci. USA 109, 3347\u20133352 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"846_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou, M. et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459\u2013468 (2011).","journal-title":"Nat. Neurosci."},{"key":"846_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nn.2778","volume":"14","author":"JR Tollervey","year":"2011","unstructured":"Tollervey, J. R. et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14, 452\u2013458 (2011).","journal-title":"Nat. Neurosci."},{"key":"846_CR31","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1242\/jcs.038950","volume":"121","author":"YM Ayala","year":"2008","unstructured":"Ayala, Y. M. et al. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121, 3778\u20133785 (2008).","journal-title":"J. Cell Sci."},{"key":"846_CR32","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1073\/pnas.1218311110","volume":"110","author":"B Schmid","year":"2013","unstructured":"Schmid, B. et al. Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc. Natl Acad. Sci. USA 110, 4986\u20134991 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"846_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.conb.2007.08.005","volume":"17","author":"MS Forman","year":"2007","unstructured":"Forman, M. S., Trojanowski, J. Q. & Lee, V. M. TDP-43: a novel neurodegenerative proteinopathy. Curr. Opin. Neurobiol. 17, 548\u2013555 (2007).","journal-title":"Curr. Opin. Neurobiol."},{"key":"846_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40478-018-0531-3","volume":"6","author":"S Nag","year":"2018","unstructured":"Nag, S. et al. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer\u2019s disease. Acta Neuropathol. Commun. 6, 33 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"846_CR35","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1001\/jamaneurol.2013.3961","volume":"70","author":"RS Wilson","year":"2013","unstructured":"Wilson, R. S. et al. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 70, 1418\u20131424 (2013).","journal-title":"JAMA Neurol."},{"key":"846_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa, M. et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60\u201370 (2008).","journal-title":"Ann. Neurol."},{"key":"846_CR37","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0900688106","volume":"106","author":"YJ Zhang","year":"2009","unstructured":"Zhang, Y. J. et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 106, 7607\u20137612 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"846_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann, M. et al. Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137\u2013149 (2009).","journal-title":"Acta Neuropathol."},{"key":"846_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.21154","volume":"61","author":"C Amador-Ortiz","year":"2007","unstructured":"Amador-Ortiz, C. et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease. Ann. Neurol. 61, 435\u2013445 (2007).","journal-title":"Ann. Neurol."},{"key":"846_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s004010050673","volume":"94","author":"A Kinoshita","year":"1997","unstructured":"Kinoshita, A., Tomimoto, H., Suenaga, T., Akiguchi, I. & Kimura, J. Ubiquitin-related cytoskeletal abnormality in frontotemporal dementia: immunohistochemical and immunoelectron microscope studies. Acta Neuropathol. 94, 67\u201372 (1997).","journal-title":"Acta Neuropathol."},{"key":"846_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00401-008-0408-9","volume":"116","author":"WL Lin","year":"2008","unstructured":"Lin, W. L. & Dickson, D. W. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 116, 205\u2013213 (2008).","journal-title":"Acta Neuropathol."},{"key":"846_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-022-02426-3","volume":"143","author":"A Tarutani","year":"2022","unstructured":"Tarutani, A. et al. Ultrastructural and biochemical classification of pathogenic tau, \u03b1-synuclein and TDP-43. Acta Neuropathol. 143, 613\u2013640 (2022).","journal-title":"Acta Neuropathol."},{"key":"846_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka, T. et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 4, 124\u2013134 (2013).","journal-title":"Cell Rep."},{"key":"846_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000109758","volume":"16","author":"LK Kwong","year":"2008","unstructured":"Kwong, L. K., Uryu, K., Trojanowski, J. Q. & Lee, V. M. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Neurosignals 16, 41\u201351 (2008).","journal-title":"Neurosignals"},{"key":"846_CR45","doi-asserted-by":"publisher","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","volume":"284","author":"BS Johnson","year":"2009","unstructured":"Johnson, B. S. et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329\u201320339 (2009).","journal-title":"J. Biol. Chem."},{"key":"846_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-021-04199-3","volume":"601","author":"D Arseni","year":"2022","unstructured":"Arseni, D. et al. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature 601, 139\u2013143 (2022).","journal-title":"Nature"},{"key":"846_CR47","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1212\/WNL.0000000000003610","volume":"88","author":"S Nag","year":"2017","unstructured":"Nag, S. et al. TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology 88, 653\u2013660 (2017).","journal-title":"Neurology"},{"key":"846_CR48","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/brain\/aww224","volume":"139","author":"BD James","year":"2016","unstructured":"James, B. D. et al. TDP-43 stage, mixed pathologies, and clinical Alzheimer\u2019s-type dementia. Brain 139, 2983\u20132993 (2016).","journal-title":"Brain"},{"key":"846_CR49","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ana.24388","volume":"77","author":"S Nag","year":"2015","unstructured":"Nag, S. et al. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann. Neurol. 77, 942\u2013952 (2015).","journal-title":"Ann. Neurol."},{"key":"846_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00401-013-1110-0","volume":"126","author":"SJ Arnold","year":"2013","unstructured":"Arnold, S. J., Dugger, B. N. & Beach, T. G. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol. 126, 51\u201357 (2013).","journal-title":"Acta Neuropathol."},{"key":"846_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","volume":"3","author":"A Uchino","year":"2015","unstructured":"Uchino, A. et al. Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol. Commun. 3, 35 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"846_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-022-02524-2","volume":"145","author":"PT Nelson","year":"2023","unstructured":"Nelson, P. T. et al. LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathol. 145, 159\u2013173 (2023).","journal-title":"Acta Neuropathol."},{"key":"846_CR53","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs, K. A. et al. Staging TDP-43 pathology in Alzheimer\u2019s disease. Acta Neuropathol. 127, 441\u2013450 (2014).","journal-title":"Acta Neuropathol."},{"key":"846_CR54","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","volume":"131","author":"KA Josephs","year":"2016","unstructured":"Josephs, K. A. et al. Updated TDP-43 in Alzheimer\u2019s disease staging scheme. Acta Neuropathol. 131, 571\u2013585 (2016).","journal-title":"Acta Neuropathol."},{"key":"846_CR55","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/nan.12309","volume":"42","author":"KA Josephs","year":"2016","unstructured":"Josephs, K. A. & Dickson, D. W. TDP-43 in the olfactory bulb in Alzheimer\u2019s disease. Neuropathol. Appl. Neurobiol. 42, 390\u2013393 (2016).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"846_CR56","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chio","year":"2013","unstructured":"Chio, A. et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41, 118\u2013130 (2013).","journal-title":"Neuroepidemiology"},{"key":"846_CR57","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942\u2013955 (2011).","journal-title":"Lancet"},{"key":"846_CR58","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/21678421.2020.1771732","volume":"21","author":"E Bersano","year":"2020","unstructured":"Bersano, E. et al. Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 373\u2013379 (2020).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"846_CR59","doi-asserted-by":"publisher","first-page":"e1370","DOI":"10.1212\/WNL.0000000000006317","volume":"91","author":"C Crockford","year":"2018","unstructured":"Crockford, C. et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 91, e1370\u2013e1380 (2018).","journal-title":"Neurology"},{"key":"846_CR60","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(07)70265-X","volume":"6","author":"J Phukan","year":"2007","unstructured":"Phukan, J., Pender, N. P. & Hardiman, O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 6, 994\u20131003 (2007).","journal-title":"Lancet Neurol."},{"key":"846_CR61","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrn1971","volume":"7","author":"P Pasinelli","year":"2006","unstructured":"Pasinelli, P. & Brown, R. H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710\u2013723 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"846_CR62","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363\u20131380 (2022).","journal-title":"Lancet"},{"key":"846_CR63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown, R. H. & Al-Chalabi, A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162\u2013172 (2017).","journal-title":"N. Engl. J. Med."},{"key":"846_CR64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia, R., Chio, A. & Traynor, B. J. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 17, 94\u2013102 (2018).","journal-title":"Lancet Neurol."},{"key":"846_CR65","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/humu.22319","volume":"34","author":"S Lattante","year":"2013","unstructured":"Lattante, S., Rouleau, G. A. & Kabashi, E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum. Mutat. 34, 812\u2013826 (2013).","journal-title":"Hum. Mutat."},{"key":"846_CR66","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/exnr.1997.6773","volume":"150","author":"CH Hawkes","year":"1998","unstructured":"Hawkes, C. H., Shephard, B. C., Geddes, J. F., Body, G. D. & Martin, J. E. Olfactory disorder in motor neuron disease. Exp. Neurol. 150, 248\u2013253 (1998).","journal-title":"Exp. Neurol."},{"key":"846_CR67","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/NEN.0000000000000198","volume":"74","author":"T Takeda","year":"2015","unstructured":"Takeda, T. et al. TDP-43 pathology progression along the olfactory pathway as a possible substrate for olfactory impairment in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 74, 547\u2013556 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-018-0528-y","volume":"6","author":"MD Cykowski","year":"2018","unstructured":"Cykowski, M. D. et al. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 6, 28 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"846_CR69","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-019-0824-1","volume":"7","author":"F Mori","year":"2019","unstructured":"Mori, F. et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol. Commun. 7, 165 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"846_CR70","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.neuron.2019.02.038","volume":"102","author":"F Gasset-Rosa","year":"2019","unstructured":"Gasset-Rosa, F. et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339\u2013357.e7 (2019).","journal-title":"Neuron"},{"key":"846_CR71","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3121","volume":"13","author":"EB Lee","year":"2011","unstructured":"Lee, E. B., Lee, V. M. & Trojanowski, J. Q. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 13, 38\u201350 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"846_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1326-7-27","volume":"7","author":"ZS Xu","year":"2012","unstructured":"Xu, Z. S. Does a loss of TDP-43 function cause neurodegeneration? Mol. Neurodegener. 7, 27 (2012).","journal-title":"Mol. Neurodegener."},{"key":"846_CR73","doi-asserted-by":"publisher","first-page":"E736","DOI":"10.1073\/pnas.1222809110","volume":"110","author":"ES Arnold","year":"2013","unstructured":"Arnold, E. S. et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl Acad. Sci. USA 110, E736\u2013E745 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"846_CR74","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1073\/pnas.1317317111","volume":"111","author":"JA Austin","year":"2014","unstructured":"Austin, J. A. et al. Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proc. Natl Acad. Sci. USA 111, 4309\u20134314 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"846_CR75","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","volume":"30","author":"SJ Barmada","year":"2010","unstructured":"Barmada, S. J. et al. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 30, 639\u2013649 (2010).","journal-title":"J. Neurosci."},{"key":"846_CR76","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.molmed.2013.11.003","volume":"20","author":"L Vanden Broeck","year":"2014","unstructured":"Vanden Broeck, L., Callaerts, P. & Dermaut, B. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis? Trends Mol. Med. 20, 66\u201371 (2014).","journal-title":"Trends Mol. Med."},{"key":"846_CR77","doi-asserted-by":"publisher","first-page":"23079","DOI":"10.1074\/jbc.M111.328757","volume":"287","author":"E Bentmann","year":"2012","unstructured":"Bentmann, E. et al. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J. Biol. Chem. 287, 23079\u201323094 (2012).","journal-title":"J. Biol. Chem."},{"key":"846_CR78","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/NEN.0000000000000102","volume":"73","author":"L McGurk","year":"2014","unstructured":"McGurk, L. et al. Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72. J. Neuropathol. Exp. Neurol. 73, 837\u2013845 (2014).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013250","volume":"5","author":"L Liu-Yesucevitz","year":"2010","unstructured":"Liu-Yesucevitz, L. et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 5, e13250 (2010).","journal-title":"PLoS One"},{"key":"846_CR80","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2019.01.048","volume":"102","author":"JR Mann","year":"2019","unstructured":"Mann, J. R. et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron 102, 321\u2013338.e8 (2019).","journal-title":"Neuron"},{"key":"846_CR81","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 22, 869\u2013878 (2016).","journal-title":"Nat. Med."},{"key":"846_CR82","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ymthe.2016.10.013","volume":"25","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Motor-coordinative and cognitive dysfunction caused by mutant TDP-43 could be reversed by inhibiting its mitochondrial localization. Mol. Ther. 25, 127\u2013139 (2017).","journal-title":"Mol. Ther."},{"key":"846_CR83","doi-asserted-by":"publisher","first-page":"107986","DOI":"10.1016\/j.neuropharm.2020.107986","volume":"167","author":"A Chio","year":"2020","unstructured":"Chio, A., Mazzini, L. & Mora, G. Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology 167, 107986 (2020).","journal-title":"Neuropharmacology"},{"key":"846_CR84","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/jpm10030101","volume":"10","author":"L Le Gall","year":"2020","unstructured":"Le Gall, L. et al. Molecular and cellular mechanisms affected in ALS. J. Pers. Med. 10, 101 (2020).","journal-title":"J. Pers. Med."},{"key":"846_CR85","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"R Mejzini","year":"2019","unstructured":"Mejzini, R. et al. ALS genetics, mechanisms, and therapeutics: where are we now? Front. Neurosci. 13, 1310 (2019).","journal-title":"Front. Neurosci."},{"key":"846_CR86","doi-asserted-by":"publisher","first-page":"103396","DOI":"10.1016\/j.mcn.2019.103396","volume":"100","author":"J Gao","year":"2019","unstructured":"Gao, J., Wang, L., Yan, T., Perry, G. & Wang, X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol. Cell Neurosci. 100, 103396 (2019).","journal-title":"Mol. Cell Neurosci."},{"key":"846_CR87","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2990.2010.01060.x","volume":"36","author":"TF Gendron","year":"2010","unstructured":"Gendron, T. F., Josephs, K. A. & Petrucelli, L. Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration. Neuropathol. Appl. Neurobiol. 36, 97\u2013112 (2010).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"846_CR88","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fmolb.2019.00154","volume":"6","author":"S Loganathan","year":"2019","unstructured":"Loganathan, S., Lehmkuhl, E. M., Eck, R. J. & Zarnescu, D. C. To be or not to be \u2026 toxic \u2014 is RNA association with TDP-43 complexes deleterious or protective in neurodegeneration? Front. Mol. Biosci. 6, 154 (2019).","journal-title":"Front. Mol. Biosci."},{"key":"846_CR89","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es, M. A. et al. Amyotrophic lateral sclerosis. Lancet 390, 2084\u20132098 (2017).","journal-title":"Lancet"},{"key":"846_CR90","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary, D. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546\u20131554 (1998).","journal-title":"Neurology"},{"key":"846_CR91","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00401-012-1029-x","volume":"124","author":"A Sieben","year":"2012","unstructured":"Sieben, A. et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 124, 353\u2013372 (2012).","journal-title":"Acta Neuropathol."},{"key":"846_CR92","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns, N. J. et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol. 114, 5\u201322 (2007).","journal-title":"Acta Neuropathol."},{"key":"846_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie, I. R. et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119, 1\u20134 (2010).","journal-title":"Acta Neuropathol."},{"key":"846_CR94","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/nan.12250","volume":"41","author":"T Lashley","year":"2015","unstructured":"Lashley, T., Rohrer, J. D., Mead, S. & Revesz, T. Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol. Appl. Neurobiol. 41, 858\u2013881 (2015).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"846_CR95","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/brain\/awg204","volume":"126","author":"SM Rosso","year":"2003","unstructured":"Rosso, S. M. et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126, 2016\u20132022 (2003).","journal-title":"Brain"},{"key":"846_CR96","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/09540261.2013.785169","volume":"25","author":"CU Onyike","year":"2013","unstructured":"Onyike, C. U. & Huey, E. D. Frontotemporal dementia and psychiatry. Int. Rev. Psychiatry 25, 127\u2013129 (2013).","journal-title":"Int. Rev. Psychiatry"},{"key":"846_CR97","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"846_CR98","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456\u20132477 (2011).","journal-title":"Brain"},{"key":"846_CR99","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006\u20131014 (2011).","journal-title":"Neurology"},{"key":"846_CR100","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1192\/bjp.180.2.140","volume":"180","author":"JS Snowden","year":"2002","unstructured":"Snowden, J. S., Neary, D. & Mann, D. M. Frontotemporal dementia. Br. J. Psychiatry 180, 140\u2013143 (2002).","journal-title":"Br. J. Psychiatry"},{"key":"846_CR101","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","volume":"127","author":"J Brettschneider","year":"2014","unstructured":"Brettschneider, J. et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol. 127, 423\u2013439 (2014).","journal-title":"Acta Neuropathol."},{"key":"846_CR102","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","volume":"388","author":"JR Burrell","year":"2016","unstructured":"Burrell, J. R. et al. The frontotemporal dementia-motor neuron disease continuum. Lancet 388, 919\u2013931 (2016).","journal-title":"Lancet"},{"key":"846_CR103","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1212\/WNL.0b013e318202038c","volume":"75","author":"JD Rohrer","year":"2010","unstructured":"Rohrer, J. D. et al. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology 75, 2204\u20132211 (2010).","journal-title":"Neurology"},{"key":"846_CR104","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1212\/WNL.0b013e31820203c2","volume":"75","author":"JL Whitwell","year":"2010","unstructured":"Whitwell, J. L. et al. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology 75, 2212\u20132220 (2010).","journal-title":"Neurology"},{"key":"846_CR105","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie, I. R. et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 122, 111\u2013113 (2011).","journal-title":"Acta Neuropathol."},{"key":"846_CR106","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","volume":"134","author":"EB Lee","year":"2017","unstructured":"Lee, E. B. et al. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol. 134, 65\u201378 (2017).","journal-title":"Acta Neuropathol."},{"key":"846_CR107","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-030-51140-1_13","volume":"1281","author":"M Neumann","year":"2021","unstructured":"Neumann, M., Lee, E. B. & Mackenzie, I. R. Frontotemporal lobar degeneration TDP-43-immunoreactive pathological subtypes: clinical and mechanistic significance. Adv. Exp. Med. Biol. 1281, 201\u2013217 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"846_CR108","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker, M. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916\u2013919 (2006).","journal-title":"Nature"},{"key":"846_CR109","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM Van Deerlin","year":"2010","unstructured":"Van Deerlin, V. M. et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42, 234\u2013239 (2010).","journal-title":"Nat. Genet."},{"key":"846_CR110","first-page":"464","volume":"22","author":"EC Finger","year":"2016","unstructured":"Finger, E. C. Frontotemporal dementias. Continuum 22, 464\u2013489 (2016).","journal-title":"Continuum"},{"key":"846_CR111","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/brain\/awaa219","volume":"143","author":"JL Robinson","year":"2020","unstructured":"Robinson, J. L. et al. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Brain 143, 2844\u20132857 (2020).","journal-title":"Brain"},{"key":"846_CR112","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/archneurol.2010.254","volume":"67","author":"F Geser","year":"2010","unstructured":"Geser, F. et al. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch. Neurol. 67, 1238\u20131250 (2010).","journal-title":"Arch. Neurol."},{"key":"846_CR113","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bpa.12424","volume":"27","author":"KE McAleese","year":"2017","unstructured":"McAleese, K. E. et al. TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing. Brain Pathol. 27, 472\u2013479 (2017).","journal-title":"Brain Pathol."},{"key":"846_CR114","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","volume":"136","author":"S Oveisgharan","year":"2018","unstructured":"Oveisgharan, S. et al. Sex differences in Alzheimer\u2019s disease and common neuropathologies of aging. Acta Neuropathol. 136, 887\u2013900 (2018).","journal-title":"Acta Neuropathol."},{"key":"846_CR115","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nly049","volume":"77","author":"LM Besser","year":"2018","unstructured":"Besser, L. M. et al. The revised national Alzheimer\u2019s coordinating center\u2019s neuropathology form \u2014 available data and new analyses. J. Neuropathol. Exp. Neurol. 77, 717\u2013726 (2018).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR116","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-018-0641-y","volume":"6","author":"Y Katsumata","year":"2018","unstructured":"Katsumata, Y., Fardo, D. W., Kukull, W. A. & Nelson, P. T. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer\u2019s disease and cerebrovascular disease pathologies. Acta Neuropathol. Commun. 6, 142 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"846_CR117","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1212\/WNL.0000000000001313","volume":"84","author":"L Yu","year":"2015","unstructured":"Yu, L. et al. The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology 84, 927\u2013934 (2015).","journal-title":"Neurology"},{"key":"846_CR118","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40478-021-01250-2","volume":"9","author":"AJ Dugan","year":"2021","unstructured":"Dugan, A. J. et al. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol. Commun. 9, 152 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"846_CR119","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","volume":"17","author":"HS Yang","year":"2018","unstructured":"Yang, H. S. et al. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study. Lancet Neurol. 17, 773\u2013781 (2018).","journal-title":"Lancet Neurol."},{"key":"846_CR120","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jamaneurol.2018.3139","volume":"75","author":"AM Wennberg","year":"2018","unstructured":"Wennberg, A. M. et al. Association of apolipoprotein E \u03b54 with transactive response DNA-binding protein 43. JAMA Neurol. 75, 1347\u20131354 (2018).","journal-title":"JAMA Neurol."},{"key":"846_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004606","volume":"10","author":"GW Beecham","year":"2014","unstructured":"Beecham, G. W. et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias. PLoS Genet. 10, e1004606 (2014).","journal-title":"PLoS Genet."},{"key":"846_CR122","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","volume":"82","author":"EC Mormino","year":"2014","unstructured":"Mormino, E. C. et al. Amyloid and APOE \u03b54 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82, 1760\u20131767 (2014).","journal-title":"Neurology"},{"key":"846_CR123","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.neurobiolaging.2013.10.074","volume":"35","author":"L Yu","year":"2014","unstructured":"Yu, L., Boyle, P. A., Leurgans, S., Schneider, J. A. & Bennett, D. A. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol. Aging 35, 819\u2013826 (2014).","journal-title":"Neurobiol. Aging"},{"key":"846_CR124","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ana.25246","volume":"84","author":"MC Power","year":"2018","unstructured":"Power, M. C. et al. Combined neuropathological pathways account for age-related risk of dementia. Ann. Neurol. 84, 10\u201322 (2018).","journal-title":"Ann. Neurol."},{"key":"846_CR125","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1750-3639.2008.00244.x","volume":"20","author":"PT Nelson","year":"2010","unstructured":"Nelson, P. T. et al. Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol. 20, 66\u201379 (2010).","journal-title":"Brain Pathol."},{"key":"846_CR126","doi-asserted-by":"publisher","first-page":"e1951","DOI":"10.1212\/WNL.0000000000010454","volume":"95","author":"A Kapasi","year":"2020","unstructured":"Kapasi, A. et al. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology 95, e1951\u2013e1962 (2020).","journal-title":"Neurology"},{"key":"846_CR127","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00401-021-02360-w","volume":"142","author":"WT Harrison","year":"2021","unstructured":"Harrison, W. T. et al. Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the oldest-old. Acta Neuropathol. 142, 917\u2013919 (2021).","journal-title":"Acta Neuropathol."},{"key":"846_CR128","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-018-1872-5","volume":"136","author":"JL Robinson","year":"2018","unstructured":"Robinson, J. L. et al. Non-Alzheimer\u2019s contributions to dementia and cognitive resilience in the 90+ Study. Acta Neuropathol. 136, 377\u2013388 (2018).","journal-title":"Acta Neuropathol."},{"key":"846_CR129","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1001\/jama.2012.3556","volume":"307","author":"BD James","year":"2012","unstructured":"James, B. D., Bennett, D. A., Boyle, P. A., Leurgans, S. & Schneider, J. A. Dementia from Alzheimer disease and mixed pathologies in the oldest old. J. Am. Med. Assoc. 307, 1798\u20131800 (2012).","journal-title":"J. Am. Med. Assoc."},{"key":"846_CR130","doi-asserted-by":"publisher","first-page":"e2056","DOI":"10.1212\/WNL.0000000000010602","volume":"95","author":"S Nag","year":"2020","unstructured":"Nag, S. et al. Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents. Neurology 95, e2056\u2013e2064 (2020).","journal-title":"Neurology"},{"key":"846_CR131","doi-asserted-by":"publisher","first-page":"S368","DOI":"10.1093\/geronb\/55.6.S368","volume":"55","author":"DW Baker","year":"2000","unstructured":"Baker, D. W., Gazmararian, J. A., Sudano, J. & Patterson, M. The association between age and health literacy among elderly persons. J. Gerontol. B Psychol. Sci. Soc. Sci. 55, S368\u2013S374 (2000).","journal-title":"J. Gerontol. B Psychol. Sci. Soc. Sci."},{"key":"846_CR132","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/j.1525-1497.2006.00539.x","volume":"21","author":"RL Sudore","year":"2006","unstructured":"Sudore, R. L. et al. Limited literacy and mortality in the elderly: the health, aging, and body composition study. J. Gen. Intern. Med. 21, 806\u2013812 (2006).","journal-title":"J. Gen. Intern. Med."},{"key":"846_CR133","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1037\/a0033103","volume":"28","author":"PA Boyle","year":"2013","unstructured":"Boyle, P. A. et al. Cognitive decline impairs financial and health literacy among community-based older persons without dementia. Psychol. Aging 28, 614\u2013624 (2013).","journal-title":"Psychol. Aging"},{"key":"846_CR134","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1177\/0898264315577780","volume":"27","author":"SD Han","year":"2015","unstructured":"Han, S. D., Boyle, P. A., James, B. D., Yu, L. & Bennett, D. A. Poorer financial and health literacy among community-dwelling older adults with mild cognitive impairment. J. Aging Health 27, 1105\u20131117 (2015).","journal-title":"J. Aging Health"},{"key":"846_CR135","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/13825585.2016.1178210","volume":"24","author":"RS Wilson","year":"2017","unstructured":"Wilson, R. S., Yu, L., James, B. D., Bennett, D. A. & Boyle, P. A. Association of financial and health literacy with cognitive health in old age. Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn. 24, 186\u2013197 (2017).","journal-title":"Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn."},{"key":"846_CR136","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3233\/JAD-161132","volume":"56","author":"L Yu","year":"2017","unstructured":"Yu, L., Wilson, R. S., Schneider, J. A., Bennett, D. A. & Boyle, P. A. Financial and health literacy predict incident Alzheimer\u2019s disease dementia and pathology. J. Alzheimers Dis. 56, 1485\u20131493 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"846_CR137","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/WAD.0000000000000334","volume":"33","author":"A Kapasi","year":"2019","unstructured":"Kapasi, A. et al. Association of TDP-43 pathology with domain-specific literacy in older persons. Alzheimer Dis. Assoc. Disord. 33, 315\u2013320 (2019).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"846_CR138","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/jnen\/nlz126","volume":"79","author":"LM Besser","year":"2020","unstructured":"Besser, L. M., Teylan, M. A. & Nelson, P. T. Limbic predominant age-related TDP-43 encephalopathy (LATE): clinical and neuropathological associations. J. Neuropathol. Exp. Neurol. 79, 305\u2013313 (2020).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR139","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2337\/diacare.29.03.06.dc05-1901","volume":"29","author":"Z Arvanitakis","year":"2006","unstructured":"Arvanitakis, Z., Wilson, R. S., Li, Y., Aggarwal, N. T. & Bennett, D. A. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29, 560\u2013565 (2006).","journal-title":"Diabetes Care"},{"key":"846_CR140","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamaneurol.2015.0910","volume":"72","author":"MA Kioumourtzoglou","year":"2015","unstructured":"Kioumourtzoglou, M. A. et al. Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study. JAMA Neurol. 72, 905\u2013911 (2015).","journal-title":"JAMA Neurol."},{"key":"846_CR141","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/ene.12632","volume":"22","author":"D Mariosa","year":"2015","unstructured":"Mariosa, D., Kamel, F., Bellocco, R., Ye, W. & Fang, F. Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur. J. Neurol. 22, 1436\u20131442 (2015).","journal-title":"Eur. J. Neurol."},{"key":"846_CR142","doi-asserted-by":"publisher","first-page":"e2694","DOI":"10.1212\/WNL.0000000000012025","volume":"96","author":"S Oveisgharan","year":"2021","unstructured":"Oveisgharan, S. et al. Association of hemoglobin A1C with TDP-43 pathology in community-based elders. Neurology 96, e2694\u2013e2703 (2021).","journal-title":"Neurology"},{"key":"846_CR143","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","volume":"117","author":"T Arai","year":"2009","unstructured":"Arai, T. et al. Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies. Acta Neuropathol. 117, 125\u2013136 (2009).","journal-title":"Acta Neuropathol."},{"key":"846_CR144","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1212\/01.wnl.0000304041.09418.b1","volume":"70","author":"KA Josephs","year":"2008","unstructured":"Josephs, K. A. et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70, 1850\u20131857 (2008).","journal-title":"Neurology"},{"key":"846_CR145","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.24493","volume":"78","author":"KA Josephs","year":"2015","unstructured":"Josephs, K. A. et al. TAR DNA-binding protein 43 and pathological subtype of Alzheimer\u2019s disease impact clinical features. Ann. Neurol. 78, 697\u2013709 (2015).","journal-title":"Ann. Neurol."},{"key":"846_CR146","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs, K. A. et al. TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease. Acta Neuropathol. 127, 811\u2013824 (2014).","journal-title":"Acta Neuropathol."},{"key":"846_CR147","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00401-018-1951-7","volume":"137","author":"KA Josephs","year":"2019","unstructured":"Josephs, K. A. et al. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains. Acta Neuropathol. 137, 227\u2013238 (2019).","journal-title":"Acta Neuropathol."},{"key":"846_CR148","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/brain\/awr053","volume":"134","author":"PT Nelson","year":"2011","unstructured":"Nelson, P. T. et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 134, 1506\u20131518 (2011).","journal-title":"Brain"},{"key":"846_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026286","volume":"6","author":"RJ Dawe","year":"2011","unstructured":"Dawe, R. J., Bennett, D. A., Schneider, J. A. & Arfanakis, K. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study. PLoS One 6, e26286 (2011).","journal-title":"PLoS One"},{"key":"846_CR150","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1212\/WNL.0000000000008679","volume":"94","author":"L Yu","year":"2020","unstructured":"Yu, L. et al. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology 94, e142\u2013e152 (2020).","journal-title":"Neurology"},{"key":"846_CR151","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/brb3.66","volume":"2","author":"C Zarow","year":"2012","unstructured":"Zarow, C., Weiner, M. W., Ellis, W. G. & Chui, H. C. Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav. 2, 435\u2013442 (2012).","journal-title":"Brain Behav."},{"key":"846_CR152","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.neurobiolaging.2006.07.010","volume":"28","author":"KA Josephs","year":"2007","unstructured":"Josephs, K. A. & Dickson, D. W. Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Neurobiol. Aging 28, 1718\u20131722 (2007).","journal-title":"Neurobiol. Aging"},{"key":"846_CR153","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00401-013-1161-2","volume":"126","author":"ME Murray","year":"2013","unstructured":"Murray, M. E. et al. Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72. Acta Neuropathol. 126, 545\u2013554 (2013).","journal-title":"Acta Neuropathol."},{"key":"846_CR154","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.seizure.2017.07.006","volume":"51","author":"S Popkirov","year":"2017","unstructured":"Popkirov, S. et al. Progressive hippocampal sclerosis after viral encephalitis: potential role of NMDA receptor antibodies. Seizure 51, 6\u20138 (2017).","journal-title":"Seizure"},{"key":"846_CR155","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/NEN.0b013e3181b05d67","volume":"68","author":"M Thom","year":"2009","unstructured":"Thom, M. et al. Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: neuropathological features. J. Neuropathol. Exp. Neurol. 68, 928\u2013938 (2009).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR156","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF00293396","volume":"88","author":"DW Dickson","year":"1994","unstructured":"Dickson, D. W. et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol. 88, 212\u2013221 (1994).","journal-title":"Acta Neuropathol."},{"key":"846_CR157","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00401-013-1154-1","volume":"126","author":"PT Nelson","year":"2013","unstructured":"Nelson, P. T. et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol. 126, 161\u2013177 (2013).","journal-title":"Acta Neuropathol."},{"key":"846_CR158","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/brain\/awt318","volume":"137","author":"JH Neltner","year":"2014","unstructured":"Neltner, J. H. et al. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 137, 255\u2013267 (2014).","journal-title":"Brain"},{"key":"846_CR159","doi-asserted-by":"publisher","first-page":"e1422","DOI":"10.1212\/WNL.0000000000200001","volume":"98","author":"KM Gauthreaux","year":"2022","unstructured":"Gauthreaux, K. M. et al. Limbic-predominant age-related TDP-43 encephalopathy: medical and pathologic factors associated with comorbid hippocampal sclerosis. Neurology 98, e1422\u2013e1433 (2022).","journal-title":"Neurology"},{"key":"846_CR160","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/WAD.0b013e31820f8f50","volume":"25","author":"WC Pao","year":"2011","unstructured":"Pao, W. C. et al. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis. Assoc. Disord. 25, 364\u2013368 (2011).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"846_CR161","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bpa.12773","volume":"30","author":"SRK Hokkanen","year":"2020","unstructured":"Hokkanen, S. R. K. et al. Putative risk alleles for LATE-NC with hippocampal sclerosis in population-representative autopsy cohorts. Brain Pathol. 30, 364\u2013372 (2020).","journal-title":"Brain Pathol."},{"key":"846_CR162","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-014-1282-2","volume":"127","author":"PT Nelson","year":"2014","unstructured":"Nelson, P. T. et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol. 127, 825\u2013843 (2014).","journal-title":"Acta Neuropathol."},{"key":"846_CR163","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.arr.2015.07.007","volume":"24","author":"PT Nelson","year":"2015","unstructured":"Nelson, P. T. et al. ABCC9\/SUR2 in the brain: implications for hippocampal sclerosis of aging and a potential therapeutic target. Ageing Res. Rev. 24, 111\u2013125 (2015).","journal-title":"Ageing Res. Rev."},{"key":"846_CR164","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nbd.2019.01.013","volume":"125","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. TDP-43 proteinopathy in aging: associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels. Neurobiol. Dis. 125, 67\u201376 (2019).","journal-title":"Neurobiol. Dis."},{"key":"846_CR165","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fendo.2014.00082","volume":"5","author":"B Morte","year":"2014","unstructured":"Morte, B. & Bernal, J. Thyroid hormone action: astrocyte-neuron communication. Front. Endocrinol. 5, 82 (2014).","journal-title":"Front. Endocrinol."},{"key":"846_CR166","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda, H. et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 114, 221\u2013229 (2007).","journal-title":"Acta Neuropathol."},{"key":"846_CR167","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","volume":"1184","author":"S Higashi","year":"2007","unstructured":"Higashi, S. et al. Concurrence of TDP-43, tau and \u03b1-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies. Brain Res. 1184, 284\u2013294 (2007).","journal-title":"Brain Res."},{"key":"846_CR168","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-021-02383-3","volume":"143","author":"MT Uemura","year":"2022","unstructured":"Uemura, M. T. et al. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease. Acta Neuropathol. 143, 15\u201331 (2022).","journal-title":"Acta Neuropathol."},{"key":"846_CR169","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s40478-021-01260-0","volume":"9","author":"S Agrawal","year":"2021","unstructured":"Agrawal, S. et al. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer\u2019s dementia in older persons. Acta Neuropathol. Commun. 9, 156 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"846_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-020-02235-6","volume":"141","author":"BL Blevins","year":"2021","unstructured":"Blevins, B. L. et al. Brain arteriolosclerosis. Acta Neuropathol. 141, 1\u201324 (2021).","journal-title":"Acta Neuropathol."},{"key":"846_CR171","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/0271678X15621574","volume":"37","author":"ET Ighodaro","year":"2017","unstructured":"Ighodaro, E. T. et al. Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J. Cereb. Blood Flow. Metab. 37, 201\u2013216 (2017).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"846_CR172","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/nan.12599","volume":"46","author":"P Bourassa","year":"2020","unstructured":"Bourassa, P., Tremblay, C., Schneider, J. A., Bennett, D. A. & Calon, F. Brain mural cell loss in the parietal cortex in Alzheimer\u2019s disease correlates with cognitive decline and TDP-43 pathology. Neuropathol. Appl. Neurobiol. 46, 458\u2013477 (2020).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"846_CR173","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12939","volume":"31","author":"S Agrawal","year":"2021","unstructured":"Agrawal, S. et al. Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons. Brain Pathol. 31, e12939 (2021).","journal-title":"Brain Pathol."},{"key":"846_CR174","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary, J. F. et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 128, 755\u2013766 (2014).","journal-title":"Acta Neuropathol."},{"key":"846_CR175","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","volume":"133","author":"KA Josephs","year":"2017","unstructured":"Josephs, K. A. et al. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol. 133, 705\u2013715 (2017).","journal-title":"Acta Neuropathol."},{"key":"846_CR176","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-018-0300-0","volume":"35","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Phosphorylated TDP-43 staging of primary age-related tauopathy. Neurosci. Bull. 35, 183\u2013192 (2019).","journal-title":"Neurosci. Bull."},{"key":"846_CR177","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/alz.12763","volume":"19","author":"MJ Grothe","year":"2023","unstructured":"Grothe, M. J. et al. Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC. Alzheimers Dement. 19, 1234\u20131244 (2023).","journal-title":"Alzheimers Dement."},{"key":"846_CR178","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2019.01.022","volume":"77","author":"N Makkinejad","year":"2019","unstructured":"Makkinejad, N. et al. Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults. Neurobiol. Aging 77, 104\u2013111 (2019).","journal-title":"Neurobiol. Aging"},{"key":"846_CR179","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neulet.2008.01.060","volume":"434","author":"HX Zhang","year":"2008","unstructured":"Zhang, H. X., Tanji, K., Mori, F. & Wakabayashi, K. Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43. Neurosci. Lett. 434, 170\u2013174 (2008).","journal-title":"Neurosci. Lett."},{"key":"846_CR180","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1007\/s12035-018-0947-6","volume":"55","author":"E Feneberg","year":"2018","unstructured":"Feneberg, E., Gray, E., Ansorge, O., Talbot, K. & Turner, M. R. Towards a TDP-43-based biomarker for ALS and FTLD. Mol. Neurobiol. 55, 7789\u20137801 (2018).","journal-title":"Mol. Neurobiol."},{"key":"846_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1091-7","volume":"18","author":"V Majumder","year":"2018","unstructured":"Majumder, V., Gregory, J. M., Barria, M. A., Green, A. & Pal, S. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. BMC Neurol. 18, 90 (2018).","journal-title":"BMC Neurol."},{"key":"846_CR182","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-008-0389-8","volume":"116","author":"P Foulds","year":"2008","unstructured":"Foulds, P. et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Acta Neuropathol. 116, 141\u2013146 (2008).","journal-title":"Acta Neuropathol."},{"key":"846_CR183","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00401-009-0594-0","volume":"118","author":"PG Foulds","year":"2009","unstructured":"Foulds, P. G. et al. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol. 118, 647\u2013658 (2009).","journal-title":"Acta Neuropathol."},{"key":"846_CR184","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cell.2013.07.038","volume":"154","author":"M Ramaswami","year":"2013","unstructured":"Ramaswami, M., Taylor, J. P. & Parker, R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 154, 727\u2013736 (2013).","journal-title":"Cell"},{"key":"846_CR185","doi-asserted-by":"publisher","DOI":"10.1038\/srep39490","volume":"6","author":"A Prasad","year":"2016","unstructured":"Prasad, A. et al. An acridine derivative, [4,5-bis{(N-carboxy methyl imidazolium)methyl}acridine] dibromide, shows anti-TDP-43 aggregation effect in ALS disease models. Sci. Rep. 6, 39490 (2016).","journal-title":"Sci. Rep."},{"key":"846_CR186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042277","volume":"7","author":"SJ Parker","year":"2012","unstructured":"Parker, S. J. et al. Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes. PLoS One 7, e42277 (2012).","journal-title":"PLoS One"},{"key":"846_CR187","doi-asserted-by":"publisher","first-page":"15024","DOI":"10.1073\/pnas.1206362109","volume":"109","author":"IF Wang","year":"2012","unstructured":"Wang, I. F. et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl Acad. Sci. USA 109, 15024\u201315029 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"846_CR188","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-016-1586-5","volume":"132","author":"S Boeynaems","year":"2016","unstructured":"Boeynaems, S., Bogaert, E., Van Damme, P. & Van Den Bosch, L. Inside out: the role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol. 132, 159\u2013173 (2016).","journal-title":"Acta Neuropathol."},{"key":"846_CR189","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tins.2011.05.002","volume":"34","author":"D Dormann","year":"2011","unstructured":"Dormann, D. & Haass, C. TDP-43 and FUS: a nuclear affair. Trends Neurosci. 34, 339\u2013348 (2011).","journal-title":"Trends Neurosci."},{"key":"846_CR190","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuron.2017.07.029","volume":"96","author":"HJ Kim","year":"2017","unstructured":"Kim, H. J. & Taylor, J. P. Lost in transportation: nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases. Neuron 96, 285\u2013297 (2017).","journal-title":"Neuron"},{"key":"846_CR191","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature14973","volume":"525","author":"K Zhang","year":"2015","unstructured":"Zhang, K. et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56\u201361 (2015).","journal-title":"Nature"},{"key":"846_CR192","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","volume":"21","author":"CC Chou","year":"2018","unstructured":"Chou, C. C. et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD. Nat. Neurosci. 21, 228\u2013239 (2018).","journal-title":"Nat. Neurosci."},{"key":"846_CR193","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25007-5","volume":"8","author":"H Ederle","year":"2018","unstructured":"Ederle, H. et al. Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1\/CRM1. Sci. Rep. 8, 7084 (2018).","journal-title":"Sci. Rep."},{"key":"846_CR194","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.tibs.2020.12.005","volume":"46","author":"B Portz","year":"2021","unstructured":"Portz, B., Lee, B. L. & Shorter, J. FUS and TDP-43 phases in health and disease. Trends Biochem. Sci. 46, 550\u2013563 (2021).","journal-title":"Trends Biochem. Sci."},{"key":"846_CR195","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","volume":"29","author":"DA Amado","year":"2021","unstructured":"Amado, D. A. & Davidson, B. L. Gene therapy for ALS: a review. Mol. Ther. 29, 3345\u20133358 (2021).","journal-title":"Mol. Ther."},{"key":"846_CR196","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/d41573-021-00181-w","volume":"20","author":"A Mullard","year":"2021","unstructured":"Mullard, A. ALS antisense drug falters in phase III. Nat. Rev. Drug Discov. 20, 883\u2013885 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"846_CR197","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1474-9728.2003.00054.x","volume":"2","author":"H Ding","year":"2003","unstructured":"Ding, H. et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2, 209\u2013217 (2003).","journal-title":"Aging Cell"},{"key":"846_CR198","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091269","volume":"9","author":"AL Nishimura","year":"2014","unstructured":"Nishimura, A. L. et al. Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells. PLoS One 9, e91269 (2014).","journal-title":"PLoS One"},{"key":"846_CR199","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41536-021-00131-5","volume":"6","author":"C Morata-Tarifa","year":"2021","unstructured":"Morata-Tarifa, C., Azkona, G., Glass, J., Mazzini, L. & Sanchez-Pernaute, R. Looking backward to move forward: a meta-analysis of stem cell therapy in amyotrophic lateral sclerosis. NPJ Regen. Med. 6, 20 (2021).","journal-title":"NPJ Regen. Med."},{"key":"846_CR200","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1091\/mbc.E15-10-0693","volume":"27","author":"J Shorter","year":"2016","unstructured":"Shorter, J. Engineering therapeutic protein disaggregases. Mol. Biol. Cell 27, 1556\u20131560 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"846_CR201","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fmolb.2016.00008","volume":"3","author":"KL Mack","year":"2016","unstructured":"Mack, K. L. & Shorter, J. Engineering and evolution of molecular chaperones and protein disaggregases with enhanced activity. Front. Mol. Biosci. 3, 8 (2016).","journal-title":"Front. Mol. Biosci."},{"key":"846_CR202","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.celrep.2019.07.069","volume":"28","author":"A Tariq","year":"2019","unstructured":"Tariq, A. et al. Mining disaggregase sequence space to safely counter TDP-43, FUS, and \u03b1-synuclein proteotoxicity. Cell Rep. 28, 2080\u20132095.e6 (2019).","journal-title":"Cell Rep."},{"key":"846_CR203","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2022.11513","volume":"328","author":"E Harris","year":"2022","unstructured":"Harris, E. Large autopsy study estimates prevalence of \u201cLATE\u201d neuropathologic change. J. Am. Med. Assoc. 328, 815\u2013816 (2022).","journal-title":"J. Am. Med. Assoc."},{"key":"846_CR204","unstructured":"He, W., Goodkind, D. & Kowal, P. in Population Reports, P95\/16-1 (eds. International US Census Bureau) (US Government Publication Office, 2016)."},{"key":"846_CR205","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12031-011-9545-z","volume":"45","author":"EH Bigio","year":"2011","unstructured":"Bigio, E. H. TDP-43 variants of frontotemporal lobar degeneration. J. Mol. Neurosci. 45, 390\u2013401 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"846_CR206","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-017-1716-8","volume":"134","author":"IR Mackenzie","year":"2017","unstructured":"Mackenzie, I. R. & Neumann, M. Reappraisal of TDP-43 pathology in FTLD-U subtypes. Acta Neuropathol. 134, 79\u201396 (2017).","journal-title":"Acta Neuropathol."},{"key":"846_CR207","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/nsmb.2698","volume":"20","author":"PJ Lukavsky","year":"2013","unstructured":"Lukavsky, P. J. et al. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 20, 1443\u20131449 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"846_CR208","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00401-007-0257-y","volume":"115","author":"F Geser","year":"2008","unstructured":"Geser, F. et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 115, 133\u2013145 (2008).","journal-title":"Acta Neuropathol."},{"key":"846_CR209","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jnen\/nlx049","volume":"76","author":"T Mishima","year":"2017","unstructured":"Mishima, T. et al. Perry syndrome: a distinctive type of TDP-43 proteinopathy. J. Neuropathol. Exp. Neurol. 76, 676\u2013682 (2017).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR210","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","volume":"15","author":"C Wider","year":"2009","unstructured":"Wider, C. et al. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat. Disord. 15, 281\u2013286 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"846_CR211","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-011-0879-y","volume":"122","author":"YS Davidson","year":"2011","unstructured":"Davidson, Y. S. et al. TDP-43 pathological changes in early onset familial and sporadic Alzheimer\u2019s disease, late onset Alzheimer\u2019s disease and Down\u2019s syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol. 122, 703\u2013713 (2011).","journal-title":"Acta Neuropathol."},{"key":"846_CR212","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/archneurol.2009.277","volume":"66","author":"CF Lippa","year":"2009","unstructured":"Lippa, C. F. et al. Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and down syndrome. Arch. Neurol. 66, 1483\u20131488 (2009).","journal-title":"Arch. Neurol."},{"key":"846_CR213","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/nen.0b013e3181609361","volume":"67","author":"SH Freeman","year":"2008","unstructured":"Freeman, S. H., Spires-Jones, T., Hyman, B. T., Growdon, J. H. & Frosch, M. P. TAR-DNA binding protein 43 in Pick disease. J. Neuropathol. Exp. Neurol. 67, 62\u201367 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"846_CR214","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00401-008-0463-2","volume":"117","author":"H Fujishiro","year":"2009","unstructured":"Fujishiro, H. et al. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease. Acta Neuropathol. 117, 151\u2013158 (2009).","journal-title":"Acta Neuropathol."},{"key":"846_CR215","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/brain\/awm065","volume":"130","author":"M Hasegawa","year":"2007","unstructured":"Hasegawa, M. et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130, 1386\u20131394 (2007).","journal-title":"Brain"},{"key":"846_CR216","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00401-009-0552-x","volume":"118","author":"CF Tan","year":"2009","unstructured":"Tan, C. F. et al. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol. 118, 553\u2013560 (2009).","journal-title":"Acta Neuropathol."},{"key":"846_CR217","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00401-011-0862-7","volume":"122","author":"Y Toyoshima","year":"2011","unstructured":"Toyoshima, Y. et al. Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol. 122, 375\u2013378 (2011).","journal-title":"Acta Neuropathol."},{"key":"846_CR218","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/neup.12038","volume":"33","author":"A Sakurai","year":"2013","unstructured":"Sakurai, A., Makioka, K., Fukuda, T., Takatama, M. & Okamoto, K. Accumulation of phosphorylated TDP-43 in the CNS of a patient with Cockayne syndrome. Neuropathology 33, 673\u2013677 (2013).","journal-title":"Neuropathology"},{"key":"846_CR219","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1523\/JNEUROSCI.0248-14.2014","volume":"34","author":"AK Walker","year":"2014","unstructured":"Walker, A. K. et al. Astrocytic TDP-43 pathology in Alexander disease. J. Neurosci. 34, 6448\u20136458 (2014).","journal-title":"J. Neurosci."},{"key":"846_CR220","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious orders study and rush memory and aging project. J. Alzheimers Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"846_CR221","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1111\/j.1532-5415.2010.03049.x","volume":"58","author":"DA Fleischman","year":"2010","unstructured":"Fleischman, D. A. et al. Regional brain cortical thinning and systemic inflammation in older persons without dementia. J. Am. Geriatr. Soc. 58, 1823\u20131825 (2010).","journal-title":"J. Am. Geriatr. Soc."},{"key":"846_CR222","first-page":"2","volume":"2","author":"S Nag","year":"2021","unstructured":"Nag, S. et al. Ex vivo MRI facilitates localization of cerebral microbleeds of different ages during neuropathology assessment. Free Neuropathol. 2, 2\u201335 (2021).","journal-title":"Free Neuropathol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00846-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T13:03:02Z","timestamp":1693314182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00846-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":222,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1038\/s41582-023-00846-7","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"26 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}